Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance, shares at Dec. 31, 2023		41,205,551
Beginning balance, amount at Dec. 31, 2023	$ 405,386	$ 41	$ 550,491		$ (145,146)
Exchange of common stock for pre-funded warrants, shares		(1,842,499)
Exchange of common stock for pre-funded warrants, value	(25)	$ (2)	(23)
Exercise of stock options, shares		5,595
Exercise of stock options, amount	26		26
Vesting of restricted stock	11		11
Stock-based compensation	3,904		3,904
Net loss	(35,811)				(35,811)
Other comprehensive loss	(279)			$ (279)
Ending balance, shares at Mar. 31, 2024		39,368,647
Ending balance, amount at Mar. 31, 2024	373,212	$ 39	554,409	(279)	(180,957)
Beginning balance, shares at Dec. 31, 2024		46,042,504
Beginning balance, amount at Dec. 31, 2024	$ 360,229	$ 46	672,540	291	(312,648)
Exercise of stock options, shares	12,447	12,447
Exercise of stock options, amount	$ 38		38
Vesting of restricted stock	7		7
Stock-based compensation	6,876		6,876
Net loss	(84,498)				(84,498)
Other comprehensive loss	(195)			(195)
Ending balance, shares at Mar. 31, 2025		46,054,951
Ending balance, amount at Mar. 31, 2025	$ 282,457	$ 46	$ 679,461	$ 96	$ (397,146)